BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31659740)

  • 1. Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial.
    Kratzer TB; Weinstein SJ; Albanes D; Mondul AM
    Int J Cancer; 2020 Aug; 147(3):669-674. PubMed ID: 31659740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
    Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
    Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort.
    Mondul AM; Weinstein SJ; Parisi D; Um CY; McCullough ML; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1203-1207. PubMed ID: 30030213
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
    Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
    Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
    Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
    Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
    Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
    Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
    Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
    Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma.
    Gibson TM; Weinstein SJ; Mayne ST; Pfeiffer RM; Selhub J; Taylor PR; Virtamo J; Albanes D; Stolzenberg-Solomon R
    Cancer Causes Control; 2010 Jul; 21(7):1061-9. PubMed ID: 20383577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Hofmann JN; Hosgood HD; Liu CS; Chow WH; Shuch B; Cheng WL; Lin TT; Moore LE; Lan Q; Rothman N; Purdue MP
    Carcinogenesis; 2014 May; 35(5):1028-31. PubMed ID: 24398668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
    Johansson M; Fanidi A; Muller DC; Bassett JK; Midttun Ø; Vollset SE; Travis RC; Palli D; Mattiello A; Sieri S; Trichopoulou A; Lagiou P; Trichopoulos D; Ljungberg B; Hallmans G; Weiderpass E; Skeie G; González CA; Dorronsoro M; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Boutron Ruault MC; Fagherazzi G; Clavel F; Sánchez MJ; Gurrea AB; Navarro C; Quiros JR; Overvad K; Tjønneland A; Aleksandrova K; Vineis P; Gunter MJ; Kaaks R; Giles G; Relton C; Riboli E; Boeing H; Ueland PM; Severi G; Brennan P
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.
    Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ
    Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
    Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
    PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
    Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
    Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
    Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
    Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
    Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
    Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.
    Southard EB; Roff A; Fortugno T; Richie JP; Kaag M; Chinchilli VM; Virtamo J; Albanes D; Weinstein S; Wilson RT
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):191-201. PubMed ID: 22086884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
    Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
    Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.